CoreWeave shares rise despite downgrade from Bank of America on valuation concerns

CoreWeave (CRWV) shares rose 5.6% despite a downgrade to Neutral from Bank of America, which cited valuation concerns after a 145% stock increase following Q1 results. While BofA raised its price target to $185, it noted CoreWeave's premium valuation at 25x estimated 2027 EBIT compared to peers at 16x, alongside projected negative free cash flow of $21 billion through 2027 due to significant capital expenditure needs, despite positive developments like a $4 billion OpenAI agreement expansion and reduced-rate debt raise.

Analysis

CoreWeave (CRWV) shares demonstrated resilience, climbing 5.6% despite a downgrade to Neutral by Bank of America, which cited a stretched valuation following a 145% stock surge after Q1 results. The bank highlighted CoreWeave's trading multiple of 25 times estimated 2027 EBIT, a premium compared to peers at 16 times. Simultaneously, Bank of America increased its price objective on CoreWeave to $185 from $76, acknowledging positive developments such as securing a new hyperscaler customer, a $4 billion expansion of its agreement with OpenAI (now totaling $15.9 billion in contract value), and a recent debt raise at a reduced interest rate of 9.3%. These factors underscore CoreWeave's strong growth and market position, especially as its largest customer, OpenAI, saw ChatGPT's weekly active users double to 800 million between February and May. However, significant financial headwinds remain, with Bank of America flagging projected negative free cash flow of $21 billion through 2027, driven by capital expenditures of $46.1 billion over the same period. While CoreWeave has historically funded 85% of capex through debt and recently raised $2 billion, this is only a fraction of its future needs, and Bank of America cautioned that the AI infrastructure capex growth rate, while still healthy, appears to be peaking, making continued access to affordable capital crucial.

Key Decisions for Investors

• Investors should carefully weigh CoreWeave's significant growth momentum, evidenced by major contract wins such as the $4 billion OpenAI expansion, against its current valuation at 25 times estimated 2027 EBIT, which Bank of America considers stretched.
• Close monitoring of CoreWeave's ability to finance its substantial $46.1 billion capital expenditure plan through 2027 and manage a projected $21 billion negative free cash flow is essential, particularly focusing on the terms and availability of future debt financing.
• Given Bank of America's assessment that much of the near-term upside is priced in and that the AI infrastructure capex growth rate may be peaking, investors might re-evaluate risk-reward profiles, especially considering the premium valuation relative to peers.